Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. | 211,203 | reported | 20 Feb 2024 | tx 87+1,881,320−510,095 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2024 | SALE | KalVista Pharmaceuticals, Inc. | 24,888 | 14.11 USD | |
| 17 Feb 2024 | EXERCISE | KalVista Pharmaceuticals, Inc. | 54,415 | — | |
| 17 Feb 2024 | EXERCISE | KalVista Pharmaceuticals, Inc. | 20,833 | 0.00 USD | deriv |
| 17 Feb 2024 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,944 | 0.00 USD | deriv |
| 17 Feb 2024 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,805 | 0.00 USD | deriv |
| 17 Feb 2024 | EXERCISE | KalVista Pharmaceuticals, Inc. | 20,833 | 0.00 USD | deriv |
| 14 Feb 2024 | SALE | KalVista Pharmaceuticals, Inc. | 58,356 | 15.01 USD | |
| 11 Feb 2024 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 122,500 | — | |
| 11 Feb 2024 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 83,333 | 0.00 USD | deriv |
| 01 Feb 2024 | SALE | KalVista Pharmaceuticals, Inc. | 9,300 | 16.18 USD | |
| 01 Feb 2024 | SALE | KalVista Pharmaceuticals, Inc. | 700 | 16.81 USD | |
| 27 Dec 2023 | SALE | KalVista Pharmaceuticals, Inc. | 30,000 | 12.02 USD | |
| 17 Nov 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 33,583 | — | |
| 20 Nov 2023 | SALE | KalVista Pharmaceuticals, Inc. | 14,807 | 8.23 USD | |
| 17 Nov 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,945 | 0.00 USD | deriv |
| 17 Nov 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 20,833 | 0.00 USD | deriv |
| 17 Nov 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,805 | 0.00 USD | deriv |
| 30 Oct 2023 | GIFT | KalVista Pharmaceuticals, Inc. | 8,000 | 0.00 USD | |
| 17 Aug 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 33,582 | — | |
| 18 Aug 2023 | SALE | KalVista Pharmaceuticals, Inc. | 14,876 | 10.73 USD | |
| 17 Aug 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,944 | 0.00 USD | deriv |
| 17 Aug 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,805 | 0.00 USD | deriv |
| 17 Aug 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 20,833 | 0.00 USD | deriv |
| 18 May 2023 | SALE | KalVista Pharmaceuticals, Inc. | 5,627 | 10.14 USD | |
| 17 May 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 12,750 | — |